Eric Meissner to HIV-1
This is a "connection" page, showing publications Eric Meissner has written about HIV-1.
Connection Strength
1.167
-
Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus. J Virol. 2006 Nov; 80(22):11019-30.
Score: 0.235
-
Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology. 2005 Jun 05; 336(2):184-97.
Score: 0.215
-
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology. 2004 Oct 10; 328(1):74-88.
Score: 0.206
-
HIV-1 replication and pathogenesis in the human thymus. Curr HIV Res. 2003 Jul; 1(3):275-85.
Score: 0.189
-
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration. AIDS Res Hum Retroviruses. 2016 May; 32(5):456-62.
Score: 0.112
-
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Sci China Life Sci. 2010 Feb; 53(2):195-203.
Score: 0.075
-
The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env. J Virol. 2009 Nov; 83(22):11715-25.
Score: 0.072
-
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies. PLoS Pathog. 2007 Aug 24; 3(8):e117.
Score: 0.063